Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1975 Mar 29;1(5960):708–712. doi: 10.1136/bmj.1.5960.708

Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris.

G Jackson, L Atkinson, S Oram
PMCID: PMC1672738  PMID: 804952

Abstract

Forty-two patients with angina pectoris have completed a randomized, double-blind trial comparing tolamolol 100 mg and 200 mg with propranolol 80 mg, practolol 100 mg, and placebo, all given three times a day. Tolamolol 200 mg thrice daily was found to be equivalent to propranolol 80 mg thrice daily in anti-anginal efficacy. Anginal attack rates and trinitrin consumption were significantly reduced by all active treatments as compared with the placebo but tolamolol and propranolol were the most effective. Tolamolol 200 mg thrice daily was most effective in reducing blood pressure, while propranolol was most effective in reducing the resting heart rate. All treatments except the placebo significantly increased the amount of exercise which could be performed before angina appeared (exercise work), while tolamolol 200 mg thrice daily significantly reduced Robinson's index when compared with all other active agents. The degree of S-T segment depression induced by exercise was significantly lessened by both tolamolol and propranolol but not by practolol or placebo. There was no difference in patient preference between tolamolol and propranolol but tolamolol at both dose levels was preferred to practolol. Both tolamolol and propranolol are potent adrenergic beta-receptor antagonists and equal in anti-anginal efficacy but tolamolol has the advantage of being cardioselective. It is superior to practolol.

Full text

PDF
708

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam K. R., Pullman L. G., Scholfield P. C. Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol. Br J Pharmacol. 1973 Nov;49(3):560–563. doi: 10.1111/j.1476-5381.1973.tb17268.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Augstein J., Cox D. A., Ham A. L., Leeming P. R., Snarey M. Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols. J Med Chem. 1973 Nov;16(11):1245–1251. doi: 10.1021/jm00269a007. [DOI] [PubMed] [Google Scholar]
  3. BEECHER H. K. The powerful placebo. J Am Med Assoc. 1955 Dec 24;159(17):1602–1606. doi: 10.1001/jama.1955.02960340022006. [DOI] [PubMed] [Google Scholar]
  4. Briant R. H., Dollery C. T., Fenyvesi T., George C. F. Assessment of selective beta-adrenoceptor blockade in man. Br J Pharmacol. 1973 Sep;49(1):106–114. doi: 10.1111/j.1476-5381.1973.tb08272.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dollery C. T., Paterson J. W., Conolly M. E. Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther. 1969 Nov-Dec;10(6):765–799. [PubMed] [Google Scholar]
  6. Dunlop D., Shanks R. G. Selective blockade of adrenoceptive beta receptors in the heart. Br J Pharmacol Chemother. 1968 Jan;32(1):201–218. doi: 10.1111/j.1476-5381.1968.tb00444.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Felix R., Ive F. A. Letter: Skin reactions to practolol. Br Med J. 1974 May 11;2(5914):333–333. doi: 10.1136/bmj.2.5914.333-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fitzgerald J. D. Perspectives in adrenergic beta-receptor blockade. Clin Pharmacol Ther. 1969 May-Jun;10(3):292–306. doi: 10.1002/cpt1969103292. [DOI] [PubMed] [Google Scholar]
  9. GILLAM P. M., PRICHARD B. N. USE OF PROPRANOLOL IN ANGINA PECTORIS. Br Med J. 1965 Aug 7;2(5457):337–339. doi: 10.1136/bmj.2.5457.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Grant R. H., Keelan P., Kernohan R. J., Leonard J. C., Nancekievill L., Sinclair K. Multicenter trial of propranolol in angina pectoris. Am J Cardiol. 1966 Sep;18(3):361–365. doi: 10.1016/0002-9149(66)90054-3. [DOI] [PubMed] [Google Scholar]
  11. HOLTER N. J. Radioelectrocardiography: a new technique for cardiovascular studies. Ann N Y Acad Sci. 1957 Aug 9;65(6):913–923. doi: 10.1111/j.1749-6632.1957.tb36693.x. [DOI] [PubMed] [Google Scholar]
  12. Hebb A. R., Godwin T. F., Gunn R. W. A new beta adrenergic blocking agent, propranolol, in the treatment of angina pectoris. Can Med Assoc J. 1968 Feb 3;98(5):246–251. [PMC free article] [PubMed] [Google Scholar]
  13. Hillis W. S., Hutton I., Lawrie T. D., Lorimer A. R., Reid J. M. The effects of a new beta-adrenoceptor blocking compound, tolamolol, on haemo-dynamics and myocardial function in man. Br J Pharmacol. 1974 May;51(1):15–19. doi: 10.1111/j.1476-5381.1974.tb09626.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. KEELAN P. DOUBLE-BLIND TRIAL OF PROPRANOLOL (INDERAL) IN ANGINA PECTORIS. Br Med J. 1965 Apr 3;1(5439):897–898. doi: 10.1136/bmj.1.5439.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kannel W. B., Feinleib M. Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol. 1972 Feb;29(2):154–163. doi: 10.1016/0002-9149(72)90624-8. [DOI] [PubMed] [Google Scholar]
  16. Livesley B., Catley P. F., Campbell R. C., Oram S. Double-blind evaluation of verapamil, propranolol, and isosorbide dinitrate against a placebo in the treatment of angina pectoris. Br Med J. 1973 Feb 17;1(5850):375–378. doi: 10.1136/bmj.1.5850.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. MCNEILL R. S. EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS. Lancet. 1964 Nov 21;2(7369):1101–1102. doi: 10.1016/s0140-6736(64)92617-0. [DOI] [PubMed] [Google Scholar]
  18. Miller R. R., Amsterdam E. A., Mason D. T. The pharmacologic basis for clinical use of beta adrenergic blocking drugs. Ration Drug Ther. 1974 Apr;8(4):1–7. [PubMed] [Google Scholar]
  19. Rabkin R., Stables D. P., Levin N. W., Suzman M. M. The prophylactic value of propranolol in angina pectoris. Am J Cardiol. 1966 Sep;18(3):370–383. doi: 10.1016/0002-9149(66)90056-7. [DOI] [PubMed] [Google Scholar]
  20. Raftery E. B., Denman A. M. Systemic lupus erythematosus syndrome induced by practolol. Br Med J. 1973 May 26;2(5864):452–455. doi: 10.1136/bmj.2.5864.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Reid D. S., Pelides L. J., Shillingford J. P. Surface mapping of RS-T segment in acute myocardial infarction. Br Heart J. 1971 May;33(3):370–374. doi: 10.1136/hrt.33.3.370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Robinson B. F. Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris. Circulation. 1967 Jun;35(6):1073–1083. doi: 10.1161/01.cir.35.6.1073. [DOI] [PubMed] [Google Scholar]
  23. Sandler G., Clayton G. A. Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris. Br Med J. 1970 May 16;2(5706):399–402. doi: 10.1136/bmj.2.5706.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sood N. K., Havard C. W. Effects of a new cardioselective beta-adrenergic blocker (tolamolol) on exercise tolerance in patients with angina pectoris. Thorax. 1973 May;28(3):331–334. doi: 10.1136/thx.28.3.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sowton E., Balcon R., Cross D., Frick H. Haemodynamic effects of I.C.I. 50172 in patients with ischaemic heart disease. Br Med J. 1968 Jan 27;1(5586):215–216. doi: 10.1136/bmj.1.5586.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sowton E., Hamer J. Hemodynamic changes after beta adrenergic blockade. Am J Cardiol. 1966 Sep;18(3):317–320. doi: 10.1016/0002-9149(66)90048-8. [DOI] [PubMed] [Google Scholar]
  27. Stephen S. A. Unwanted effects of propranolol. Am J Cardiol. 1966 Sep;18(3):463–472. doi: 10.1016/0002-9149(66)90071-3. [DOI] [PubMed] [Google Scholar]
  28. Thadani U., Sharma B., Meeran M. K., Majid P. A., Whitaker W., Taylor S. H. Comparison of adrenergic beta-receptor antagonists in angina pectoris. Br Med J. 1973 Jan 20;1(5846):138–142. doi: 10.1136/bmj.1.5846.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wolfson S., Heinle R. A., Herman M. V., Kemp H. G., Sullivan J. M., Gorlin R. Propranolol and angina pectoris. Am J Cardiol. 1966 Sep;18(3):345–353. doi: 10.1016/0002-9149(66)90052-x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES